Erman Akkus, bevacizumab

Erman Akkus: Neoadjuvant IO in colon/rectal cancers

Erman Akkus posted on X:

“Neoadjuvant IO in colon/rectal cancers.

  • pCR rates.
  • Grade 3/4 irAE.
  • Time to surgery.”

Erman Akkus
Source: Erman Akkus/X

Erman Akkus is a medical oncology fellow at the Ankara University, Faculty of Medicine. Previously, he was an Internal Medicine Resident at the Ankara University, Faculty of Medicine. He was also a Visiting Researcher at the University of Oslo. He completed his education from the Medical University of Vienna.